Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3706_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
33 Мб
Скачать
50
History
Segmental BP
Impr
ARTIFACTUALLY HIGH PRESSURES
ex
https://t.me/med1917
Fig. 4.1 Sample report of segmental pressures with ABIs and toe pressures. Only the left dorsal pedis is compressible, and the ABI is calculated based on this pressure. The three other tibial vessels are noncompressible due to calcication, consistent with the tibial disease seen in patients with diabetes. This patient was found to have a toe pressure of 0 on the right and 60mmHg on the left
N. J. Swerdlow and A. D. Hamdan
RIGHT 3RD TOE NECROSIS
Right Left
Brachial:
Ankle (PT):
Ankle (DP):
Digit:
essions
SIGNIFICANT RIGHT MULTI LEVEL DISEASE AND LEFT TIBIAL DISEASE
138
Index
>254 -NC-
>254 -NC-
0 0.00
Brachial:
Ankle (PT):
Ankle (DP):
Digit:
139
Ind
>254 -NC-
74 0.53
60 0.43
30 mmHg correlates with poor diabetic foot ulcer healing [19]. Other thresholds, specically 40 and 55mmHg, have also been proposed to dene inadequate perfusion for heal­ing diabetic foot ulcers [18, 20]. Beyond an absolute cutoff, the toe pressure can be used to dene the ischemia score in a patient’s WIfI score [14].
Doppler Waveform Analysis
A normal peripheral artery is dened by its triphasic wave­form on Doppler waveform analysis—a brisk upstroke of forward ow during systole, reversal of ow in early dias­tole, and nally a component of forward ow in late diastole. With upstream stenosis or occlusion, the waveform initially loses its reversal of ow, leading to a biphasic waveform, and as the upstream disease becomes more severe, it ultimately widens and dampens to a monophasic waveform [21]. During a Doppler waveform exam, the waveform is depicted visu­ally at various arterial levels from the common femoral artery to the ankle or toe (Fig.4.2). Doppler waveforms are not affected by medial calcication, and thus they can be used to demonstrate normal perfusion at the level of the ankle even with noncompressible tibial vessels. Changes in the nature of the waveform can also aid in the determination of the level of hemodynamically signicant occlusive dis­ease, including the ability to exclude severe aortoiliac occlu­sive disease in patients with triphasic common femoral artery waveforms.
Pulse Volume Recordings (PVRs)
Plethysmography measures changes in volume in a limb caused by arterial ow. Pulse volume recordings (PVRs) use plethysmography to create a visual representation of the changes in limb volume that occur at various levels of the limb with each heartbeat (Fig.4.3). To obtain a PVR, a pneu­matic cuff is placed at various levels of the lower extremity
(most commonly high thigh, low thigh, calf, ankle, and metatarsal) and inated to ~60mmHg. An oscillating wave­form is produced as changes in volume at each level are detected with each beat [22]. A normal PVR has a brisk upstroke and rapid downslope. With upstream arterial dis­ease, the slope of the up- and downstroke decreases, as well as the overall amplitude. While attempts have been made to quantify PVR, it largely remains a qualitative exam, particu­larly useful for interlimb comparisons within the same patient. However, it has been shown that PVRs in conjunc­tion with ABIs add to the accuracy of PAD diagnosis in com­parison to ABI alone [23].
Transcutaneous Oxygen Tension (TcPO2)
Transcutaneous oxygen tension (TcPO2) measurements assess the metabolic state of the underlying tissue by esti­mating the partial pressure of oxygen. The test is performed by placing an electrode on the dorsal aspect of the proximal foot and heating the tissue to 42–45°C.After allowing equil­ibration, the local oxygen tension is recorded in mmHg [11,
24]. Typically, a value less than 20mmHg is associated with
severe ischemia and poor wound healing, while values greater than 60mmHg are normal. However, varying differ­ent cutoffs have been proposed, and the optimal cutoff to predict adequate tissue perfusion for healing remains unclear. Additionally, many factors besides arterial circulation can affect the results, including age, edema, and infection [25,
26]. Nevertheless, TcPO2 measurement is an important
adjunct in the diagnosis of PAD in patients with diabetes and can be used to determine the grade of ischemia when calcu­lating the WIfI score [14].
Arterial Duplex Ultrasound
The above noninvasive modalities for the assessment of PAD in patients with diabetes all focus on the assessment of the
4 Clinical Features andDiagnosis ofPeripheral Arterial Disease
https://t.me/med1917
51
Fig. 4.2 Sample report of lower extremity Doppler waveform analysis. This patient has normal, triphasic waveforms in the bilateral common femoral and mid-supercial femoral arteries. On the left, the patient has a triphasic popliteal waveform and monophasic posterior tibial and dor-
adequacy of tissue perfusion. An arterial duplex ultrasound, on the other hand, begins to give information on the patient’s arterial anatomy and the specic lesions contributing to the patient’s PAD.Duplex scanning is traditionally comprised of dual modalities, B-mode imaging, and pulsed wave Doppler spectral frequency analysis. In actuality, most modern duplex scans are “triplex,” also including color-ow imaging. B-mode allows for the measurement of vessel diameter as
salis pedis waveforms consistent with tibial disease. On the right, the popliteal waveform is also monophasic, suggesting concurrent distal supercial femoral and/or popliteal disease
well as identifying characteristics of atherosclerotic disease, such as intima-media thickening and plaque composition. Doppler spectral analysis quanties the velocity of ow in a specic segment of the vessel. Based on well-dened criteria, the peak systolic velocity correlates to the degree of stenosis. Finally, color ow imaging can be used to conrm the direc­tion of ow and identify areas of turbulence or elevated or reduced velocities within a segment of a specic artery [27].
52
https://t.me/med1917
N. J. Swerdlow and A. D. Hamdan
Fig. 4.3 Sample pulse volume recording report. The thigh waveforms are normal with a sharp upstroke and diachronic notch. Distally, wave­forms become more blunted, suggesting an upstream arterial disease.
While used as a primary screening and operative planning modality in carotid disease, the role of arterial duplex in the screening and initial assessment of PAD is more limited. In patients with diabetes specically, the results of duplex ultra­sound may be limited by heavy arterial calcication. The results are also operator dependent and time-consuming, fur­ther limiting their utility in the initial evaluation of PAD.However, duplex ultrasound is an excellent modality to follow the characteristics and severity of a specic lesion and
The right metatarsal and digital waveforms are essentially at, a sug­gestion of severe ischemia
also makes up the mainstay of surveillance following both open and endovascular lower extremity revascularization [27, 28].
Computed Tomographic Angiography
Computed tomographic angiography (CTA) provides high- quality axial imaging, specically timed and proto-
4 Clinical Features andDiagnosis ofPeripheral Arterial Disease
https://t.me/med1917
abc
53
Fig. 4.4 Coronal reconstructions of a CTA aortoiliac with runoff. (a) The peripheral arterial system from the abdominal aorta through the proximal tibial vessels. Calcic atherosclerotic disease can be seen at multiple levels bilaterally. (b and c) Representative images of the right
coled for the assessment of arterial anatomy. When used to evaluate lower extremity PAD, the scan includes the full extent of the lower extremity circulation from the infrarenal aorta to the toes (Fig.4.4). Overall, CTA is an excellent tool to evaluate the overall burden of PAD and
and left tibial vasculature. The extent of stenosis in calcic atheroscle­rotic tibial lesions can be difcult to evaluate due to the small caliber of the tibial arteries
the location and anatomic features of specic atheroscle­rotic lesions. It is particularly useful for the assessment of suprainguinal disease and disease in the common femoral artery and proximal supercial femoral artery. However, the assessment of luminal patency is limited by calcica-
54
https://t.me/med1917
N. J. Swerdlow and A. D. Hamdan
tion, especially in smaller vessels. Therefore, the assess­ment of infrapopliteal vessels in patients with diabetes can be severely limited. Additionally, the quality of imag­ing is dependent on the timing of contrast injection and contrast ow, and thus severe proximal disease or slow forward ow due to heart disease can lead to poor opaci­cation of the distal vessels and thus studies that are dif­cult to interpret.
In addition to these limitations, unlike the above nonin­vasive modalities, which are essentially risk-free, CTA does carry some risks due to the need for contrast injection and thus the risk of contrast-induced nephropathy (CIN). The awareness of and concern regarding CIN increased in the 1980s concurrent with increases in the use of both diag­nostic tests and interventional procedures using intrave­nous contrast administration. It was quickly identied that patients with both chronic kidney disease and diabetes are at elevated risk for CIN [29]. However, more recent studies have suggested that earlier assessments of the risk of CIN may have been overestimated. The risk of CIN in patients with normal renal function, with or without diabetes, is now believed to be negligible. However, patients with an estimated glomerular ltration rate of less than 30 mL/ min/1.73m2 or less than 45mL/min/1.73m2 with diabetes do remain at an elevated risk of CIN [30]. Additionally, there is also a risk of contrast allergy and radiation expo­sure in patients undergoing repeated CT scans. Therefore, CTA should be used with caution in diabetic patients with coexisting renal dysfunction and should be avoided in patients with renal dysfunction and without concern for signicant suprainguinal disease.
Invasive Diagnostic Testing
Despite advances in the noninvasive assessment of PAD, angiography, and specically digital subtraction angiogra­phy (DSA), remains the gold standard for the anatomic assessment of PAD (Fig. 4.5). While it provides excellent images for the entire lower extremity vasculature, it provides particularly high-quality images of the tibial and pedal ves­sels, especially compared to noninvasive modalities such as duplex ultrasound and CTA. DSA images are also not com­promised by arterial calcication, even in small caliber ves­sels, and thus it is of particular benet in the pattern of infrapopliteal disease seen frequently in patients with diabe­tes. DSA does require the use of contrast and thus carries a risk of CIN when iodinated contrast is used. However, in patients at increased risk for CIN, carbon dioxide can be used as an alternate contrast agent. It is safe, provides excel­lent quality imaging—especially of larger caliber vessels— and eliminates the risk of CIN [31, 32]. While its utility in the assessment of the infrapopliteal vascular can be limited, carbon dioxide angiography can be supplemented with dilute iodinated contrast for the most distal images, resulting in a complete, high-quality lower extremity angiogram com­pleted with minimal iodinated contrast use.
Overall, DSA is the gold standard for the anatomic assess­ment of PAD, especially in patterns of disease typical for patients with diabetes, and is critical for revascularization planning. It also allows for endovascular treatment in the same setting if deemed appropriate. DSA and both endovas­cular and open lower extremity revascularization are dis­cussed in detail in Chap. 24.
4 Clinical Features andDiagnosis ofPeripheral Arterial Disease
https://t.me/med1917
55
a
bcd
Fig. 4.5 Digital subtraction angiography (DSA) images of a left lower extremity angiogram demonstrating (a) the common femoral artery, profunda femoris artery, and proximal supercial femoral artery; (b) the distal supercial femoral artery and above-knee popliteal artery; (c) the proximal tibial vessels; and (d) the distal tibial vessels and pedal
vessels. This pattern of disease with minimal atherosclerotic disease in the femoral and popliteal segments with severe tibial disease, in this case specically anterior and posterior tibial artery occlusion, is fre­quently seen in patients with diabetes
56
https://t.me/med1917
N. J. Swerdlow and A. D. Hamdan
Algorithm
Figure 4.6 depicts a basic algorithm for the initial assessment of PAD in patients with diabetes. All patients with diabetes should undergo a thorough history and physical exam. The history should specically assess for symptoms of ischemia and prior ulcers and wound healing. The physical exam should include a full lower extremity pulse exam, assess for signs of ischemia, and include a detailed description of any ulcers, gangrene, and evidence of infection. All patients should undergo measurement of ABI every 5years, as per the
Fig. 4.6 Algorithm depicting the initial evaluation of peripheral arterial disease.
ABI ankle-brachial index, WIfI wound, ischemia, and
foot ischemia
American Diabetes Association consensus panel on PAD [12]. If this is normal, it should be repeated every 5years. All patients with evidence of PAD based on ABI and/or history and physical exam should undergo a further assessment of lower extremity perfusion. At our institution, we begin with segmental pressures, including toe pressure with Doppler waveforms and PVRs (Figs.4.1, 4.2, and 4.3). Based on these results, all patients should have the WIfI score calculated (Table4.1). Patients who are likely to benet from revascular­ization should subsequently proceed to DSA for detailed ana­tomic assessment, operative planning, and concurrent endovascular revascularization if deemed appropriate.
4 Clinical Features andDiagnosis ofPeripheral Arterial Disease
https://t.me/med1917
57
References
1. Fowkes FGR, Aboyans V, Fowkes FJI, McDermott MM, Sampson UKA, Criqui MH. Peripheral artery disease: epidemiology and global perspectives. Nat Rev Cardiol. 2017;14(3):156–70. https://
doi.org/10.1038/nrcardio.2016.179.
2. Fowkes FGR, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analy­sis. Lancet. 2013;382(9901):1329–40. https://doi.org/10.1016/
S0140- 6736(13)61249- 0.
3. Song P, Rudan D, Zhu Y, et al. Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Heal. 2019;7(8):e1020–30. https://doi.org/10.1016/
S2214- 109X(19)30255- 4.
4. Barnes JA, Eid MA, Creager MA, Goodney PP.Epidemiology and risk of amputation in patients with diabetes mellitus and peripheral artery disease. Arterioscler Thromb Vasc Biol. 2020;40(8):1808–
17. https://doi.org/10.1161/ATVBAHA.120.314595.
5. Thiruvoipati T. Peripheral artery disease in patients with diabe­tes: epidemiology, mechanisms, and outcomes. World J Diabetes. 2015;6(7):961. https://doi.org/10.4239/wjd.v6.i7.961.
6. Marso SP, Hiatt WR. Peripheral arterial disease in patients with diabetes. J Am Coll Cardiol. 2006;47(5):921–9. https://doi.
org/10.1016/j.jacc.2005.09.065.
7. Akbari CM, LoGerfo FW. Diabetes and peripheral vascular dis­ease. J Vasc Surg. 1999;30(2):373–84. https://doi.org/10.1016/
S0741- 5214(99)70154- 0.
8. Horton WB, Barrett EJ.Microvascular dysfunction in diabetes mel­litus and cardiometabolic disease. Endocr Rev. 2021;42(1):29–55.
https://doi.org/10.1210/endrev/bnaa025.
9. Gibbons GW, Shaw PM. Diabetic vascular disease: charac­teristics of vascular disease unique to the diabetic patient. Semin Vasc Surg. 2012;25(2):89–92. https://doi.org/10.1053/j.
semvascsurg.2012.04.005.
10. Reiber GE, Smith DG, Vileikyte L, etal. Causal pathways for inci­dent lower-extremity ulcers in patients with diabetes from two set­tings. Diabetes Care. 1999;22(1):157–62. https://doi.org/10.2337/
diacare.22.1.157.
11. Brownrigg JRW, Schaper NC, Hinchliffe RJ.Diagnosis and assess­ment of peripheral arterial disease in the diabetic foot. Diabet Med. 2015;32(6):738–47. https://doi.org/10.1111/dme.12749.
12. Boulton AJM, Armstrong DG, Albert SF, et al. Comprehensive Foot Examination and Risk Assessment. A report of the Task Force of the Foot Care Interest Group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diabetes Care. 2008;31(8):1679–85.
https://doi.org/10.2337/DC08- 9021.
13. Lin JS, Olson CM, Johnson ES, Whitlock EP. The ankle­brachial index for peripheral artery disease screening and car­diovascular disease prediction among asymptomatic adults: a systematic evidence review for the U.S. preventive services task force. Ann Intern Med. 2013;159(5):333–41. https://doi.
org/10.7326/0003- 4819- 159- 5- 201309030- 00007.
14. Mills JL, Conte MS, Armstrong DG, etal. The society for vascular surgery lower extremity threatened limb classication system: risk stratication based on wound, ischemia, and foot infection (WIfI). J Vasc Surg. 2014;59(1):220–234.e2. https://doi.org/10.1016/j.
jvs.2013.08.003.
15. Hicks CW, Canner JK, Sherman RL, Black JH, Lum YW, Abularrage CJ. Evaluation of revascularization benet quartiles using the wound, ischemia, and foot infection classication sys­tem for diabetic patients with chronic limb-threatening ischemia. J Vasc Surg. 2021;74(4):1232–1239.e3. https://doi.org/10.1016/j.
jvs.2021.03.017.
16. Weaver ML, Hicks CW, Canner JK, etal. The Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classication system predicts wound healing better than direct angiosome per­fusion in diabetic foot wounds. J Vasc Surg. 2018;68(5):1473–81.
https://doi.org/10.1016/j.jvs.2018.01.060.
17. Conte MS, Bradbury AW, Kolh P, et al. Global vascular guide­lines on the management of chronic limb-threatening ischemia. J Vasc Surg. 2019;69(6):3S–125S.e40. https://doi.org/10.1016/j.
jvs.2019.02.016.
18. Carter SA, Tate RB. The value of toe pulse waves in determina­tion of risks for limb amputation and death in patients with periph­eral arterial disease and skin ulcers or gangrene. J Vasc Surg. 2001;33(4):708–14. https://doi.org/10.1067/mva.2001.112329.
19. Tay WL, Lo ZJ, Hong Q, Yong E, Chandrasekar S, Tan GWL.Toe pressure in predicting diabetic foot ulcer healing: a systematic review and meta-analysis. Ann Vasc Surg. 2019;60:371–8. https://
doi.org/10.1016/j.avsg.2019.04.011.
20. Brownrigg JRW, Hinchliffe RJ, Apelqvist J, etal. Performance of prognostic markers in the prediction of wound healing or ampu­tation among patients with foot ulcers in diabetes: a systematic review. Diabetes Metab Res Rev. 2016;32:128–35. https://doi.
org/10.1002/dmrr.2704.
21. Johnston KW, Maruzzo BC, Cobbold RSC. Doppler methods for quantitative measurement and localization of peripheral arte­rial occlusive disease by analysis of the blood ow velocity waveform. Ultrasound Med Biol. 1978;4(3):209–23. https://doi.
org/10.1016/0301- 5629(78)90053- 4.
22. Osmundson PJ, O’Fallon WM, Clements IP, Kazmier FJ, Zimmerman BR, Palumbo PJ.Reproducibility of noninvasive tests of peripheral occlusive arterial disease. J Vasc Surg. 1985;2(5):678–
83. https://doi.org/10.1016/0741- 5214(85)90037- 0.
23. Hashimoto T, Ichihashi S, Iwakoshi S, Kichikawa K.Combination of pulse volume recording (PVR) parameters and ankle-brachial index (ABI) improves diagnostic accuracy for peripheral arterial disease compared with ABI alone. Hypertens Res. 2016;39(6):430–
4. https://doi.org/10.1038/hr.2016.13.
24. Quigley FG, Faris IB.Transcutaneous oxygen tension measurements in the assessment of limb ischaemia. Clin Physiol. 1991;11(4):315–
20. https://doi.org/10.1111/j.1475- 097X.1991.tb00660.x.
25. Leenstra B, Wijnand J, Verhoeven B, etal. Applicability of transcu­taneous oxygen tension measurement in the assessment of chronic limb-threatening ischemia. Angiology. 2020;71(3):208–16. https://
doi.org/10.1177/0003319719866958.
26. Leenstra B, De Kleijn R, Kuppens G, Verhoeven BAN, Hinnen JW, De Borst GJ. Photo-optical transcutaneous oxygen tension mea­surement is of added value to predict diabetic foot ulcer healing: an observational study. J Clin Med. 2020;9(10):1–9. https://doi.
org/10.3390/jcm9103291.
27. Harrington A, Kupinski AM. Noninvasive studies for the periph­eral artery disease patient. Semin Vasc Surg. 2022;35(2):132–40.
https://doi.org/10.1053/j.semvascsurg.2022.04.009.
28. Abu Dabrh AM, Mohammed K, Farah W, etal. Systematic review and meta-analysis of duplex ultrasound surveillance for infrain­guinal vein bypass grafts. J Vasc Surg. 2017;66(6):1885–1891.e8.
https://doi.org/10.1016/j.jvs.2017.06.113.
58
https://t.me/med1917
N. J. Swerdlow and A. D. Hamdan
29. Parfrey PS, Grifths SM, Barrett BJ, et al. Contrast material­induced renal failure in patients with diabetes mellitus, renal insuf­ciency, or both. N Engl J Med. 1989;320(3):143–9. https://doi.
org/10.1056/nejm198901193200303.
30. Rudnick MR, Leonberg-Yoo AK, Litt HI, Cohen RM, Hilton S, Reese PP. The controversy of contrast-induced nephropathy with intravenous contrast: what is the risk? Am J Kidney Dis. 2020;75(1):105–13. https://doi.org/10.1053/j.ajkd.2019.05.022.
31. Ali M, Noureldin M, El Kashef O, Zaghlol H.Safety and effective­ness of carbon dioxide contrast medium in infra-inguinal endovas­cular interventions for patients with chronic threatening lower limb ischemia and renal impairment: a multicentric trial. J Endovasc Ther.
2023. ePUB ahead; https://doi.org/10.1177/15266028231159241.
32. Seeger JM, Self S, Harward TRS, etal. Carbon dioxide gas as an arterial contrast agent. Ann Surg. 1993;217(6):688–98. https://doi.
org/10.1097/00000658- 199306000- 00011.
Imaging ofInfection in
https://t.me/med1917
the Diabetic Foot
MaryG.Hochman andCaitlinConnolly
5
Abstract
Information derived from imaging studies can play an important role in the management of complicated foot problems in a diabetic patient. This chapter reviews the various modalities available for the imaging of infection in the diabetic foot—radiography; nuclear medicine stud­ies such as bone scans, labeled leukocyte scans, bone marrow scans, and ourine-18-ourodeoxyglucose positron- emission tomography (FDG PET) scans; cross­sectional studies such as magnetic resonance imaging (MRI), MR spectroscopy, computed tomography (CT), and ultrasound—and highlights their relative strengths and weaknesses for the diagnosis of osteomyelitis, soft tissue infection, and neuroarthropathy. A suggested imag­ing algorithm for the diagnosis of osteomyelitis in the dia­betic foot is presented.
Introduction
Foot infections are among the most common causes of hos­pitalization in the diabetic population, accounting for 20% of all diabetes-related admissions. Complicated foot infections may require treatment by amputation—as many as 6–10% of all diabetic patients will undergo amputation for the treat­ment of infection [13], accounting for 57% of nontraumatic lower extremity amputations [46]. The scope of the prob­lem is compelling [7]. In 2016, 130,000 hospital discharges
for lower extremity amputation in the United States were associated with a diagnosis of diabetes [8]. The Centers for Disease Control and Prevention (CDC) estimated the annual treatment cost of amputees related to infection and compli­cated vascular diabetic foot problems at $1.2billion for the year 1997, not including the cost of rehabilitation, prosthetic devices, or lost income. These treatment costs are likely to grow as the prevalence of diabetes is on the rise. The esti­mated prevalence of diagnosed and undiagnosed diabetes is
24.2 million people, representing 10.5% of all US adults,
with a prevalence of 26% among US adults 65years or older [8]. In 2013, the prevalence of diabetes was estimated to be 382 million people worldwide, and this number was pro­jected to rise to 592million by 2035 [9].
Information derived from imaging studies can play an important role in the management of complicated foot prob­lems in the diabetic patient. Soft tissue abnormalities such as abscesses and cellulitis can be identied, osteomyelitis can be detected, the extent of abnormal marrow can be depicted, neuroarthropathic changes can be diagnosed and followed over time, the distribution of atherosclerotic lesions can be mapped, and the effectiveness of revascularization proce­dures can be evaluated. A variety of studies are currently available for imaging the diabetic foot. In order to use these imaging studies effectively, it is important to understand the specic strengths and weaknesses of each modality as they apply to the particular clinical problem in question. The goal of this chapter will be to review the modalities available for the imaging of diabetic foot infection and to highlight their relative utilities in the context of clinical problem-solving.
M. G. Hochman (*) Department of Radiology, Harvard Medical School, Musculoskeletal Imaging and Intervention, Beth Israel Deaconess Medical Center, Boston, MA, USA e-mail: mhochman@bidmc.harvard.edu
C. Connolly Nuclear Medicine, Department of Radiology, Mount Auburn Hospital, Cambridge, MA, USA e-mail: Caitlin.Connolly@mah.harvard.edu
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2024 A. Veves et al. (eds.), The Diabetic Foot, Contemporary Diabetes, https://doi.org/10.1007/978-3-031-55715-6_5
Infection intheDiabetic Foot
Risk Factors
Many factors contribute to infection in the diabetic foot, including peripheral neuropathy [10] and vascular insuf­ciency [11]. Repetitive minor trauma to an insensitive neuro-
59